Saponins have been extensively used as adjuvants in leishmaniasis vaccines, successfully triggering a Th1-type response and activation of both CD4+ and CD8+ T cell-subtypes in immunized dogs [46] and in a mouse model [25]. The gene discussed is CD8A; the disease is leishmaniasis.